UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
This piece weighs the advantages and trade-offs of blockchain and Bitcoin, offering practical guidance for newcomers evaluating crypto paths.
22,504 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Palantir has been in the AI spotlight, but its stock has traded volatile. This guide helps you separate hype from fun...
Private-market buyers are circling Anthropic as rumors of a massive follow-on round surface, pushing a volatile priva...
A major fund took a $61 million stake in a leading self-storage REIT just as a blockbuster $10.5 billion deal was win...
Pony AI's Q1 2026 earnings transcript is a pivotal moment for investors. This article breaks down the key numbers, th...
Looking to build retirement wealth with a focus on AI? This guide highlights three AI stocks worth holding until reti...
The stock move is sharp, but so is the story behind choice hotels stock down. An investor dumped more than $100 milli...
Oil prices fell after Trump signaled a near term peace agreement, with front month WTI and Brent easing from earlier ...
Dogecoin slips again, but a niche on-chain model points to a long-term accumulation floor. As traders debate a possib...
Investors are scanning for AI leaders beyond the obvious names. This article builds a case for why Broadcom could be ...
With the housing market cooling, investors are redirecting capital toward durable infrastructure plays. This report e...
When Alexander Zverev clinched his Grand Slam, attention swiveled to Sophia Thomalla. This article dives into her car...